AMY CLIFTON: Open Payments
NPI 1932351582 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 37 payments from 10 companies in 2025. Trend: 2023 $1,155 · 2024 $1,091 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $146 |
| Novartis Pharmaceuticals Corporation | 13 | $140 |
| PFIZER INC. | 6 | $90 |
| Philips North America LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Amgen Inc. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| Kestra Medical Technology Services, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Iovance Biotherapeutics, Inc. | 1 | $15 |
Products named: Wegovy, LEQVIO, ELIQUIS, ECC Solutions, FRUZAQLA, REPATHA, FARXIGA, Assure WCD.
Industry payments across AR — which companies pay providers there.
